Koyfin Home > Directory > Health Care > Aimmune Therap > EV / Sales (ntm)

Aimmune Therap EV / Sales (ntm) Chart (AIMT)

Aimmune Therap annual/quarterly EV / Sales (ntm) from 2018 to 2020.
  • Aimmune Therap EV / Sales (ntm) for the quarter ending October 10, 2020 was 58.57 a 0.19% increase of 0.11 year over year
  • Aimmune Therap EV / Sales (ntm) for the last 12 months ending October 10, 2020 was 58.57 a 0.19% increase of 0.11 year over year
  • Aimmune Therap Annual EV / Sales (ntm) for 2020 was 58.57 a -0.31% decrease of -0.18 from 2019
  • Aimmune Therap Annual EV / Sales (ntm) for 2020 was 58.75 a 0.50% increase of 0.29 from 2019
  • Aimmune Therap Annual EV / Sales (ntm) for 2020 was 58.46 a 0.00% decrease of 0.00 from 2019
Other Valuation Metrics:
  • Aimmune Therap Market Cap for the quarter ending March 03, 2018 was $1,841m a 43.79% increase of 806m year over year
  • Aimmune Therap Price / Book for the quarter ending March 03, 2018 was 9.15 a 57.27% increase of 5.24 year over year
  • Aimmune Therap Enterprise Value for the quarter ending March 03, 2018 was $1,659m a 52.45% increase of 870m year over year
View Chart On Koyfin

Quarterly AIMT EV / Sales (ntm) Data

10/202058.57
10/202058.75
10/202058.46
10/202058.46
10/202058.44
10/202058.48
10/202058.31
10/202058.48
09/202057.77
09/202057.59

Annual AIMT EV / Sales (ntm) Data

202058.57
202058.75
202058.46
202058.46
202058.44
202058.48
202058.31
202058.48
202057.77
202057.59